Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Jun 16, 2024 1:31pm
115 Views
Post# 36091179

RE:RE:Management gave no follow up details

RE:RE:Management gave no follow up details

mdjbrown wrote: piduks, is it possible ANVISA is holding up the announcement party?

I havent seen any press releases out of Brazil lately from ANVISA regarding CBD approvals for any companies, and yet corporations are making those claims.

Something appears a tad out of alignment........



 

Saying a government entity is slow is like saying the sun rises in the east.  That said, it's of less importance that whatever LABS is waiting on and much more important that they receive a nice PO.  If we use Stada as an example, one doesn't always lead to the other.  So sure, waiting on this Brazil announcement is fair game to break the boredom, but if the announcement doesn't come with a firm and large order, it might amount to a whole lotta nothing.  

<< Previous
Bullboard Posts
Next >>